Which has the lower trailing P/E, ABBV or MRK?

MRK has the lower trailing P/E: ABBV trades at 125.98 and MRK at 36.83. P/E is one valuation measure and does not by itself establish which business is cheaper.

Which has grown faster, ABBV or MRK?

Over the past five years, MRK grew revenue faster — ABBV at a 4.59% CAGR versus MRK at 8.60%.

Does ABBV or MRK pay a bigger dividend?

ABBV yields 2.62% and MRK yields 2.57% based on trailing dividends and the latest price.

Is ABBV or MRK more profitable?

MRK runs the higher net margin — ABBV at 5.79% versus MRK at 13.62%.

How have ABBV and MRK total returns compared?

Over the past 10 years, ABBV delivered 19.57% and MRK delivered 12.27% annualized total return. Past performance doesn't predict future results.

AbbVie Inc. (ABBV) vs Merck & Co., Inc. (MRK)

A side-by-side comparison of AbbVie Inc. and Merck & Co., Inc. across valuation, profitability, dividends, and growth — built entirely from reported fundamentals, as of July 28, 2026. Differences are shown without an overall score or investment verdict.

ABBV

AbbVie Inc.

$465.51B

$263.48HealthcareDelayed quote: Jul 28, 2026, 4:00 PM EDT

MRK

Merck & Co., Inc.

$325.61B

$131.84HealthcareDelayed quote: Jul 28, 2026, 3:59 PM EDT

Total return — ABBV vs MRK

growth of $100 · dividends reinvested · last 14y

ABBV +1164.7%MRK +375.8%ABBV compounded faster

ABBV MRK

ABBV vs MRK: by the numbers

•ABBV is the larger company ($465.51B vs $325.61B market cap).
•MRK trades at the lower trailing earnings multiple (36.83 vs 125.98 P/E), one valuation lens rather than an overall verdict.
•MRK converts more revenue to profit (13.62% vs 5.79% net margin).
•MRK grew revenue faster over the past five years (8.60% vs 4.59% CAGR).
•ABBV pays the higher dividend yield (2.62% vs 2.57%).

Metrics side by side

Valuation

Metric	ABBV	MRK
P/E ratio	125.98	36.83
Forward P/E	N/A	47.09
P/S ratio	7.26	4.93
P/B ratio	16.57	7.05
PEG ratio	N/A	1.81
EV / EBITDA	20.46	15.16
FCF yield	4.58%	4.37%

Profitability

Metric	ABBV	MRK
Gross margin	70.68%	75.91%
Operating margin	27.60%	36.17%
Net margin	5.79%	13.62%
ROE	13.23%	19.48%
ROIC	12.97%	18.27%

Dividends

Metric	ABBV	MRK
Dividend yield	2.62%	2.57%
Payout ratio	284.39%	46.03%

Growth (annualized)

Metric	ABBV	MRK
Revenue CAGR (5Y)	4.59%	8.60%
EPS CAGR (5Y)	-2.79%	21.21%
FCF CAGR (5Y)	3.24%	15.69%
Total return CAGR (5Y)	21.24%	14.44%

Frequently asked

Which has the lower trailing P/E, ABBV or MRK?: MRK has the lower trailing P/E: ABBV trades at 125.98 and MRK at 36.83. P/E is one valuation measure and does not by itself establish which business is cheaper.
Which has grown faster, ABBV or MRK?: Over the past five years, MRK grew revenue faster — ABBV at a 4.59% CAGR versus MRK at 8.60%.
Does ABBV or MRK pay a bigger dividend?: ABBV yields 2.62% and MRK yields 2.57% based on trailing dividends and the latest price.
Is ABBV or MRK more profitable?: MRK runs the higher net margin — ABBV at 5.79% versus MRK at 13.62%.
How have ABBV and MRK total returns compared?: Over the past 10 years, ABBV delivered 19.57% and MRK delivered 12.27% annualized total return. Past performance doesn't predict future results.

Go deeper

Full ABBV analysis Full MRK analysis Interactive comparison tool

Dig into the metrics

AbbVie P/E ratio Merck & P/E ratio AbbVie dividend yield Merck & dividend yield AbbVie ROE Merck & ROE AbbVie operating margin Merck & operating margin AbbVie revenue growth Merck & revenue growth AbbVie free cash flow Merck & free cash flow

AbbVie & Merck & appear in these rankings

Highest Dividend Yield Stocks 25+ Year Dividend Growers Highest ROIC Stocks Highest Operating Margin Stocks

Figures are sourced from reported fundamentals and the latest end-of-day price. This comparison is informational only and is not investment advice. Past performance does not predict future results. See our methodology. Compiled by TGMCharts Research · data verified July 28, 2026.